HLB Pharmaceutical Co., Ltd. (KOSDAQ: 047920)
South Korea
· Delayed Price · Currency is KRW 26,100
-200 (-0.76%)
Jan 22, 2025, 3:00 PM KST
93.48% (1Y)
| Market Cap | 369.31B |
| Revenue (ttm) | 36.10B |
| Net Income (ttm) | 472.66M |
| Shares Out | 14.04M |
| EPS (ttm) | 34.13 |
| PE Ratio | 781.36 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 185,967 |
| Average Volume | 353,173 |
| Open | 26,000 |
| Previous Close | 26,300 |
| Day's Range | 25,900 - 26,500 |
| 52-Week Range | 13,450 - 42,050 |
| Beta | 0.44 |
| RSI | 61.10 |
| Earnings Date | n/a |